WFL 0.00% 0.3¢ wellfully limited

gsk, page-4

  1. 5,800 Posts.
    lightbulb Created with Sketch. 744
    Exciting for OBJ holders. Well done.
    By reference to phase II are they referring to phase II clinical trials or phase II of a 'strategy'?

    If it is phase II clinical trials, then I wouldn't expect this to take too long,
    Can be relatively small numbers and if as mentioned to do with sensitive teeth, then recruitment should be easy.
    Particularly smart if phase II is being done oversees, as much more difficult to complete them here.

    Further more, if the product is OTC, approval will be a breeze, and the trials will be done for 'clinical claim' reasons, which GSK would probably IMO, know if it works or not already.

    Apologies if I have misunderstood anything and good luck !!!!

 
watchlist Created with Sketch. Add WFL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.